Trends in end-of-life (EOL) systemic oncologic treatment in contemporary clinical practice: insights from real-world data Published September 2021 Citation Canavan, M, Wang, X, Ascha, MS, Miksad, RA, Showalter, TN, Calip, GS, Gross, CP. . ASCO Quality Care Symposium. . https://ascopubs.org/doi/abs/10.1200/JCO.2020.39.28_suppl.253 Authors:Canavan, M, Wang, X, Ascha, MS, Miksad, RA, Showalter, TN, Calip, GS, Gross, CP Sources:ASCO Quality Care Symposium Share Posted inPublicationsTreatment patterns More publicationsWorld Conference on Lung CancerAugust 2025Evolving treatment patterns in early-stage non-small cell lung cancer in the USGray J E, Thoele K, Gilligan A M, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world biomarker testing and treatment initiation in patients with resected early-stage NSCLC (eNSCLC) in the US and UKRinaldi C, Halloran S, Pittel H, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world treatment patterns and clinical outcomes in patients with metastatic neuroendocrine neoplasms of the lung (NEN-L)Zu K, Vaidya R, Cho-Phan C, Hu H.Publication summaryPublicationsTreatment patternsNon-small cell lung cancer